USPTO serial 79288401
Reviewed by CopyMark Law Group
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Electronic publications; publications in electronic form; downloadable electronic publications; publications in electronic form supplied online from a computer database of the internet; downloadable electronic publications relating to genomics, the structure, function, evolution, mapping, and editing of genomes, DNA sequencing, mapping and analysis, bioinformatics and medical research; downloadable software in the nature of a mobile application enabling the creation of virtual gene panels and their viewing and commenting on by others; mobile telephone software; software to enable the viewing of website content via personal and handheld computers and mobile devices; downloadable software in the nature of a mobile application; downloadable mobile application software; downloadable software for use in wireless telecommunications devices; downloadable software in the nature of a mobile application relating to genomics, the structure, function, evolution, mapping, and editing of genomes, DNA sequencing, mapping and analysis, bioinformatics and medical research | ACTIVE | — |
| 042 | Research and development in the field of genomics; advisory, consultancy, analysis and research services relating to the structure, function, evolution, mapping, and editing of genomes; providing scientific analysis and informational reports based upon results of laboratory testing in the field of genomics; providing online computer databases featuring information based on aggregated results of genotyping; DNA sequencing, mapping and analysis; bioinformatics; medical research; application service provider (ASP) services; providing temporary use of non-downloadable software; design and development of non-downloadable software to enable the viewing of website content via personal and handheld computers and mobile devices; providing temporary use of non-downloadable software to enable the viewing of website content via personal and handheld computers and mobile devices; provision of non-downloadable software applications through a website, virtual community, social networking site, shared use of text, images and audio-visual content; creation and maintenance of the aforesaid; providing temporary use of non-downloadable software to enable the viewing of website content via personal and handheld computers and mobile devices relating to genomics, the structure, function, evolution, mapping, and editing of genomes, DNA sequencing, mapping and analysis, bioinformatics and medical research; application service provider (ASP) services relating to genomics, the structure, function, evolution, mapping, and editing of genomes, DNA sequencing, mapping and analysis, bioinformatics and medical research; providing temporary use of non-downloadable software to enable the viewing of website content via personal and handheld computers and mobile devices enabling the creation of virtual gene panels and their viewing and commenting on by others; application service provider (ASP) services enabling the creation of virtual gene panels and their viewing and commenting on by others; advisory, consultancy and information services relating to all the aforesaid | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 11, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 26, 2022 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 4, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 4, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 19, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 1, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 1, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 4, 2021 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 4, 2021 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 12, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 21, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 20, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 15, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 14, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 7, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 3, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 29, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 25, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |